Visual and otologic manifestation of Camurati–Engelmann's disease: a case report  by Alam, Tariq et al.
ww.sciencedirect.com
R a d i o l o g y C a s e R e p o r t s 1 0 ( 2 0 1 5 ) 6 1e6 4Available online at wScienceDirect
journal homepage: ht tp: / /E lsevier .com/locate/radcrCase ReportVisual and otologic manifestation of
CamuratieEngelmann's disease: a case reportTariq Alam MBBS, FCPSa, Muhammad Khurram MBBSb,
Hidayatullah Hamidi MDa,*, Asif Alam Khan MBBS, MDc
a Radiology Department, French Medical University for Children (FMIC), Kabul 1006, Afghanistan
b Radiology Department, Agha Khan University (AKU), Karachi, Pakistan
c Affordable Care Organization, New York State Elite, New York, USAa r t i c l e i n f o
Article history:
Received 6 July 2015
Accepted 23 August 2015
Available online 9 October 2015Competing Interests: The authors have dec
* Corresponding author.
E-mail address: Hedayatullah.hamidi@gm
http://dx.doi.org/10.1016/j.radcr.2015.08.003
1930-0433/Copyright © 2015, the Authors. Pu
an open access article under the CC BY-NC-a b s t r a c t
CamuratieEngelmann’s disease (CED) is a rare disorder worldwide with just over 200 cases
reported. No case of CED has been reported in Afghanistan till date. Most patients of CED (also
known as progressive diaphyseal dysplasia and oeteopathica hyperostotica multiplex
infantalis) present with extremity pain, muscle weakness, and waddling gait. It tends to be
bilateral and symmetrical and can affect any bone but has greater affinity for long bones e.g.,
humerus, femur, tibia, ulna, and radius. Other common sites include skull and pelvis.
Symptomatology relating to cranial nerve impingement is secondary to amorphous increase
in the density of skull bones resulting in stenosis of various foramina/spaces within skull.
Copyright © 2015, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Case presentation
A 9-year-old boy presented to his clinician with a history of
gradual loss of hearing and vision in both eyes over the pre-
ceding 7months. He was also complaining of pain localized to
his calf and thigh muscles. There was no history of joint
swelling. He had been previously well with no relevant
medical history.
Clinical examination revealed the child to be pale,
lethargic, and having a waddling gait.
Based on the clinical history, his clinician referred him for
magnetic resonance imaging of the brain to exclude any space
occupying lesion which may be the cause of his hearing and
visual loss.lared that no competing
ail.com (H. Hamidi).
blished by Elsevier Inc. u
ND license (http://creativHis magnetic resonance imaging revealed marked
hyperostosis of the skull vault bones and the base of skullwhich
is appearing hypointense on T2-weighted images (Fig. 1).
Marked narrowing of bilateral optic nerve canal due to
hyperostosis. The optic nerves can be seen compressed in the
region of bilateral optic canals (Fig. 2).
Sclerosis is also seen in the region of petrous part of tem-
poral bone which may be the reason for hearing loss.
Sclerosis of the visualized upper cervical vertebrae also
seen.
Findings were suggestive of CamuratieEngelmann's dis-
ease (CED). After discussion with the primary physician
radiograph of left femur was performed which revealed
diffuse diaphyseal hyperostosis (Fig. 3).interests exist.
nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1 e T2-weighted coronal image of the brain revealed
marked hyperostosis of the entire calvarium (arrow),
temporal bone (arrow), and visualized cervical vertebra
(arrow).
Fig. 2 e T2-weighted axial image of the brain showing
marked narrowing of bilateral optic canals (arrows) due to
excessive hyperostosis.
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Camurati Engelmann's disease (CED) also known as progres-
sive diaphyseal dysplasia (PDD) or oeteopathica hyperostotica
multiplex infantalis is a rare disorder caused by domain spe-
cific mutations in transforming growth factor (TGF)-b1 gene
on chromosome 19q13.1 [1e3]. Its pattern of inheritance is
autosomal dominant with variable penetrance [4]. It tends to
be bilateral and symmetrical and can affect any bone but has
greater affinity for long bones e.g., humerus, femur, tibia, ulna
and radius. Other common sites include skull and pelvis [5,6].
Medical treatment of bony abnormalities with glucocorti-
coids (prednisolone) has been tried with success in patients of
CED [7,8] but failure of treatment with bisphosphonates has
also been reported [9].
Moumoulidis et al. [10] described otologicalmanifestation in
CED as a result of narrowing of internal auditory canals caused
by bony encroachment on nerves and vessels. This results in
retrocochlear hearing loss, meanwhile, the narrowing of tym-
panic cavities and Eustachian tube may precipitate middle ear
infectionsand/oradhesionsofosciles to the tympanicwalls [11].
The incidence of hearing impairment in the patients of CED
is estimated to be about 18% [12]. Cochlear implantation for
auditory rehabilitation in patients of CED has been described
by Friedland et al. [11] and Tibesar [13]. Surgical decompres-
sion of internal auditory meatus to relieve vertigo in case of
CED has also been successfully done [14].
Visual manifestation of CED can be considered as late
sequelae of disease process. Wright M et al. [15] reported that
visual symptoms may take some time to develop.Initial symptommay only be of exophthalmos or headache
due to raised intracranial pressure, and a decrease in visual
acuity may be the presentation later in the disease process
[15]. It maywell be the chief presenting symptoms as with this
case.
Visual symptoms are not limited to CED alone, other con-
ditions of primary bone disorders such as craniometaphyseal
dysplasia, osteopetrosis, and aneurysmal bone cyst, all of
which have been reported to cause progressive stenosis of
optic canals [16e18]. The etiology of visual symptoms in some
case have been presumed to have occurred solely due to
compressive optic neuropathy[19,20]; however, symptoms
can also be because of papilloedema secondary to raised
intracranial pressure [15].
In our case, visual symptoms were because of marked
narrowing of bilateral optic nerve canal due to hyperostosis.
The optic nerves can be seen compressed in the region of
bilateral optic canals (Fig 2).
Treatment rationale will be different as papilloedema has
been treated with diuretics (acetazolamide) [15] and surgical
decompression reported as the best management in cases of
compressive optic neuropathy. However, in some cases and
overlap of both mechanisms may be encountered. It is sug-
gested that some type of cranial vault expansion procedure,
possibly combined with an orbital decompression may be
beneficial as well [15].
Here it should be kept in mind that, surgery may not be
curative and reconstitution of surgically resected bonemay be
encountered [19,21].
In conclusion, the report describes the first case ever of
CED to be reported from Afghanistan and its presenting
symptomatology.
Fig. 3 e Radiograph of right femur anterioposterior view revealed diffuse diaphyseal hyperostosis.
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